Clinical trial
Lung EpiCheck Biomarkers Development Study
NCT06245876 is registered in ClinicalTrials.gov with Nucleix Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lung EpiCheck Biomarkers Development Study
- Lead sponsor
- Nucleix Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 17, 2022
- Completion date
- January 31, 2026
- Enrollment
- 2,132 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer